Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 6
2006 5
2007 4
2008 7
2009 5
2010 7
2011 12
2012 11
2013 6
2014 10
2015 12
2016 9
2017 11
2018 10
2019 9
2020 11
2021 15
2022 19
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis.
Dong J, Ng WT, Wong CHL, Li JS, Bollen H, Chow JCH, Eisbruch A, Lee AWM, Lee VHF, Ng SP, Nuyts S, Smee R, Ferlito A. Dong J, et al. Among authors: lee awm. Radiother Oncol. 2024 Mar 26;195:110258. doi: 10.1016/j.radonc.2024.110258. Online ahead of print. Radiother Oncol. 2024. PMID: 38537680 Free article. Review.
Clinical research for global needs of radiation oncology.
Baumann M, Bacchus C, Aznar MC, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Lee AWM, Löck S, Offersen BV, Thwaites DI, van der Heide UA, Valentini V, Overgaard J. Baumann M, et al. Among authors: lee awm. Radiother Oncol. 2024 Jan;190:110076. doi: 10.1016/j.radonc.2023.110076. Epub 2023 Dec 28. Radiother Oncol. 2024. PMID: 38157941 No abstract available.
Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial.
Chiang CL, Lam TC, Li JCB, Chan KSK, El Helali A, Lee YYP, Law LHT, Zheng D, Lo AWI, Kam NW, Li WS, Cheung AKW, Chow JCH, Chan SPC, Lai JWY, Lee SWM, Kong FS, Ng WT, Kwong DLW, Lee AWM. Chiang CL, et al. Lancet Reg Health West Pac. 2023 Sep 6;40:100898. doi: 10.1016/j.lanwpc.2023.100898. eCollection 2023 Nov. Lancet Reg Health West Pac. 2023. PMID: 37701718 Free PMC article.
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours.
El Helali A, Lam TC, Ko EY, Shih DJH, Chan CK, Wong CHL, Wong JWH, Cheung LWT, Lau JKS, Liu APY, Chan ASY, Loong HH, Lam STS, Chan GC, Lee VHF, Yuen KK, Ng WT, Lee AWM, Ma ESK. El Helali A, et al. Among authors: lee awm. Lancet Reg Health West Pac. 2023 Apr 28;36:100775. doi: 10.1016/j.lanwpc.2023.100775. eCollection 2023 Jul. Lancet Reg Health West Pac. 2023. PMID: 37547050 Free PMC article.
Adjuvant chemotherapy in nasopharyngeal carcinoma.
Yip PL, Lee AWM, Chua MLK. Yip PL, et al. Among authors: lee awm. Lancet Oncol. 2023 Jul;24(7):713-715. doi: 10.1016/S1470-2045(23)00266-8. Epub 2023 Jun 5. Lancet Oncol. 2023. PMID: 37290469 No abstract available.
159 results